NASDAQ:SESN • US8177631053
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SESEN BIO INC (SESN).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-08-16 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2021-02-17 | Canaccord Genuity | Maintains | Buy |
| 2021-02-17 | HC Wainwright & Co. | Maintains | Buy |
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 11.24M | 26.544M 136.16% | -100.00% | ||||||||||
| EBITDA YoY % growth | -108.27M -215.75% | -20.96M 80.64% | 28.764M 237.23% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -108.49M -214.46% | -21.08M 80.57% | 28.679M 236.05% | -80.807M -381.77% | -16.626M 79.43% | -6.63M 60.12% | -7.14M -7.69% | -7.752M -8.57% | -8.058M -3.95% | -8.16M -1.27% | -8.16M | -8.262M -1.25% | |
| Operating Margin | N/A | -187.54% | 108.04% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -1.20 -122.22% | -0.23 80.83% | -0.10 56.52% | -0.41 -1,900.00% | -0.09 95.41% | -0.03 66.67% | -0.02 33.33% | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
6 analysts have analysed SESN and the average price target is 12.24 USD. This implies a price increase of 1846.56% is expected in the next year compared to the current price of 0.6288.
SESEN BIO INC (SESN) will report earnings on 2023-05-08.
The number of analysts covering SESEN BIO INC (SESN) is 6.